On Friday, SyntheticMR announced that Ulrik Harrysson, who has been on medical leave since 4 December, has resigned from his role as CEO. Vedran Beglerbegovic, currently acting CEO and previous Chief Operating Officer, has been appointed new CEO with immediate effect. The change in leadership comes as SyntheticMR enters a new phase following the acquisition of Combinostics. Given Mr Beglerbegovic's previous experience from SyntheticMR, we expect the change to be undramatic.

Link to the analysis